Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common and invasive malignant tumors in the world. The change in DNA methylation is a key event in HCC. METHODS: Methylation datasets for HCC and 17 other types of cancer were downloaded from The Cancer Genome Atlas (TCGA). The CpG sites...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rui-kun, Liu, Jia-lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214801/
https://www.ncbi.nlm.nih.gov/pubmed/34147096
http://dx.doi.org/10.1186/s12920-021-01015-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214801/
https://www.ncbi.nlm.nih.gov/pubmed/34147096
http://dx.doi.org/10.1186/s12920-021-01015-9

Ejemplares similares